Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.53 |
| ▸ | PAM | P19021 | 2/20 | 0.48 |
| ▸ | CNR2 | P34972 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.44 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.44 |
| ▸ | PLIN1 | O60240 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | RECQL | P46063 | 2/20 | 0.44 |
| ▸ | PLIN5 | Q00G26 | 2/20 | 0.44 |
| ▸ | ABHD5 | Q8WTS1 | 2/20 | 0.44 |
| ▸ | TNKS | O95271 | 1/20 | 0.44 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.44 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.44 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6406292 | 0.84 | ALDH1A1 (0.51) | CYP1A2PAMCNR2ALDH1A1HDAC3 | |
| SCHEMBL7941808 | 0.83 | CYP1A2 (0.47) | CYP1A2PAMCNR2ALDH1A1HDAC3 | |
| SCHEMBL27487715 | 0.82 | CNR2 (0.54) | CYP1A2PAMCNR2ALDH1A1HDAC3 | |
| SCHEMBL27342140 | 0.81 | CYP1A2 (0.53) | CYP1A2PAMCNR2ALDH1A1HDAC3 | |
| SCHEMBL11069954 | 0.81 | CYP1A2 (0.53) | CYP1A2PAMCNR2ALDH1A1HDAC3 | |
| SCHEMBL9306609 | 0.81 | CPA1 (0.44) | CYP1A2PAMALDH1A1HDAC3HDAC4 | |
| SCHEMBL29083692 | 0.81 | PAM (0.52) | CYP1A2PAMCNR2ALDH1A1HDAC3 | |
| SCHEMBL11580231 | 0.81 | PPARA (0.49) | CYP1A2PAMCNR2ALDH1A1HDAC3 | |
| SCHEMBL29209801 | 0.80 | CYP1A2 (0.51) | CYP1A2PAMCNR2ALDH1A1HDAC3 | |
| SCHEMBL9632505 | 0.80 | PPARG (0.53) | CYP1A2CNR2HDAC3HDAC4HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070014756-A1 | Composition and method for treating the gastro-intestinal tract | TOUCHOT NICHOLAS | 2007-01-18 | — | — | US | disclosed |
| US-20040191318-A1 | Composition and method for treating the gastro-intestinal tract | VILLITECH SARL (FR) | 2004-09-30 | — | — | US | disclosed |
| EP-1462116-A1 | Composition for treating the gastrointestinal tract | Villitech SARL (FR) | 2004-09-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070014756-A1 | Composition and method for treating the gastro-intestinal tract | GIPR, FABP2, FABP6 | CYP1A2 1784/4885PAM 298/4885CNR2 196/4885 |
| US-20040191318-A1 | Composition and method for treating the gastro-intestinal tract | GIPR, FABP2, FABP6 | CYP1A2 1784/4885PAM 298/4885CNR2 196/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.